Systematic treatment for breast cancer patients 1.Surgical treatment For most of the breast cancer patients, surgical treatment is still the first treatment means. The main surgical methods include modified radical mastectomy, radical mastectomy and breast cancer surgery with breast preservation. Surgery can remove the lesion, improve the patient’s quality of life and prolong the patient’s life. Doctors make the most appropriate choice of surgery by judging the patient’s condition and consulting with the patient. 2.Adjuvant chemotherapy A large number of clinical trials have proved that chemotherapy can significantly increase the survival rate and improve the quality of life of breast cancer patients. Chemotherapy includes post-surgical adjuvant chemotherapy and pre-surgical neoadjuvant chemotherapy. Neoadjuvant chemotherapy is the opposite of traditional adjuvant post-operative chemotherapy. Neoadjuvant chemotherapy can shrink 50% to 70% of the masses, reduce clinical staging, and create conditions for breast conservation for patients with breast-conserving intentions. Moreover, neoadjuvant chemotherapy can visually observe the changes of the swelling after the drug is administered, which indicates the direction for postoperative drug use. 3.Adjuvant endocrine therapy Normal breast epithelial cells contain a variety of hormone receptors, such as estrogen receptor (ER) and progesterone receptor (PR), etc. After breast cancer occurs, some breast cancers can retain some or all of the functions of hormone receptors and become hormone-dependent tumors. Endocrine therapy is for this part of patients. The physician will choose appropriate endocrine therapy drugs according to the patient’s menstrual status, such as triamcinolone acetonide (tamoxifen), anastrozole (Renindezvous), letrozole, exemestane, etc. 4.Radiotherapy In the treatment of breast cancer, radiotherapy has a very important role. It can not only improve the control rate of local and regional lesions, but also improve the long-term survival rate of breast cancer patients. The greater contribution of radiation therapy is that it makes breast-conserving surgery possible. Molecular targeted therapy is to use specific genes or gene expression products that can be expressed by tumor cells but not or rarely expressed by normal cells to form a target to maximize the killing of tumor cells. The c-erbB-2 gene has become an important player in the molecular targeted therapy for breast cancer. Trastuzumab (Herceptin) is a drug that targets this target and has been unanimously recognized worldwide for the treatment of patients with c-erbB-2 gene overexpression in breast cancer. 6.Chinese medicine treatment The use of Chinese medicine with chemotherapy can reduce the side effects of chemotherapy and improve the effect of chemotherapy, which has been widely used in clinical practice. It is important to note that patients need to go to a regular hospital for consultation, and should not think that listening to advertisements will delay treatment.